Verona Pharma plc
VRNA
$105.27
$0.070.07%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 9.12% | 0.41% | 18.96% | -16.94% | 58.74% |
| Total Receivables | 27.65% | 82.76% | 198.28% | 239.06% | -67.86% |
| Inventory | 18.88% | 15.92% | 44.82% | -- | -- |
| Prepaid Expenses | 1.02% | 49.44% | -4.91% | 46.59% | 50.00% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -70.11% | 373.67% | -20.56% | 33.66% | 37.39% |
| Total Current Assets | 9.55% | 10.46% | 24.52% | -12.50% | 53.14% |
|
|
|||||
| Total Current Assets | 9.55% | 10.46% | 24.52% | -12.50% | 53.14% |
| Net Property, Plant & Equipment | -10.25% | -9.36% | 56.09% | -11.64% | -9.54% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -9.19% | 230.02% | -- | -- | -- |
| Total Assets | 8.92% | 10.90% | 24.21% | -12.05% | 49.74% |
|
|
|||||
| Total Accounts Payable | -62.17% | -19.43% | 64.92% | 64.52% | -10.73% |
| Total Accrued Expenses | 26.06% | 106.20% | -2.48% | -6.71% | 137.39% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -5.94% | -40.34% | 89.81% | -7.66% | -7.78% |
| Total Finance Division Other Current Liabilities | -96.09% | -18.59% | 533.48% | -92.12% | 3,097.42% |
| Total Other Current Liabilities | -96.09% | -18.59% | 533.48% | -92.12% | 3,097.42% |
| Total Current Liabilities | -9.38% | 32.48% | 52.70% | -42.19% | 227.24% |
|
|
|||||
| Total Current Liabilities | -9.38% | 32.48% | 52.70% | -42.19% | 227.24% |
| Long-Term Debt | 0.29% | 7.08% | 88.12% | 0.27% | 146.54% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -12.23% | -14.99% | -8.01% | -8.73% | -7.86% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | 5.90% | -- |
| Total Liabilities | -1.58% | 11.00% | 7.30% | -5.46% | 309.48% |
|
|
|||||
| Common Stock & APIC | 4.87% | 4.94% | 16.38% | 0.76% | 2.19% |
| Retained Earnings | 2.02% | -2.91% | -6.42% | -8.89% | -17.11% |
| Treasury Stock & Other | 7.30% | 4.11% | -15.31% | 6.46% | 1.34% |
| Total Common Equity | 22.81% | 10.77% | 56.76% | -22.45% | -25.21% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 22.81% | 10.77% | 56.76% | -22.45% | -25.21% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 22.81% | 10.77% | 56.76% | -22.45% | -25.21% |
|
|
|||||